Patrizia Trenta
Overview
Explore the profile of Patrizia Trenta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taccogna S, Gozzi E, Rossi L, Caruso D, Conte D, Trenta P, et al.
World J Gastrointest Oncol
. 2020 Oct;
12(9):1073-1079.
PMID: 33005300
Background: Breast metastases from colorectal cancer (CRC) are very uncommon. There is no unanimous consensus regarding the best treatment for this rare condition, and management is, especially in elderly patients,...
2.
Gozzi E, Angelini F, Rossi L, Leoni V, Trenta P, Cimino G, et al.
Medicine (Baltimore)
. 2020 Jul;
99(27):e21004.
PMID: 32629718
Rationale: Choroidal metastasis is a rare metastatic location although the most common intraocular neoplasm. In general, choroidal metastases respond favorably to systemic therapy targeted toward the primary neoplasm. In patients...
3.
Gozzi E, Rossi L, Angelini F, Leoni V, Trenta P, Cimino G, et al.
Thorac Cancer
. 2020 Mar;
11(5):1330-1333.
PMID: 32141197
Granulomatous dermatitis (GD) is the most common among a variety of skin reactions that may occur in the varicella-zoster virus (VZV) reactivation area. It is thought that the formation of...
4.
Mahjoubi L, Cecchi F, Massard C, Calabro F, Gazzah A, Bahleda R, et al.
Tumori
. 2018 May;
104(6):NP38-NP41.
PMID: 29714649
Introduction: Diffuse gastric cancer is associated with poor prognosis. We report a patient with metastatic gastric linitis plastica harboring human epidermal growth factor receptor 2 () activating mutation and amplification....
5.
Nicolazzo C, Raimondi C, Francescangeli F, Ceccarelli S, Trenta P, Magri V, et al.
Int J Biol Markers
. 2017 Jun;
32(4):e415-e420.
PMID: 28604994
Background: Several studies have raised the issue of the inadequacy of CellSearch® to detect the entire pool of circulating tumor cells (CTCs) from blood of cancer patients, suggesting that cells...
6.
Trenta P, Calabro F, Cerbone L, Sternberg C
Curr Treat Options Oncol
. 2016 Jan;
17(1):6.
PMID: 26810055
In the last 25 years, there has been an improved understanding of the pathogenesis of muscle-invasive bladder cancer (BC). Development of new treatment strategies has followed. We have progressed from...
7.
Iacovelli R, Modica D, Palazzo A, Trenta P, Piesco G, Cortesi E
Can Urol Assoc J
. 2015 Jun;
9(3-4):E172-7.
PMID: 26085875
Introduction: We describe clinical features and prognostic factors of renal medullary carcinoma (RMC) by performing a pooled analysis of all reported cases since 1995. Methods: A systematic search was performed...
8.
Giovannoni S, Trenta P
J Gynecol Oncol
. 2014 Oct;
25(4):355-6.
PMID: 25310036
No abstract available.
9.
Vici P, Pizzuti L, Natoli C, Moscetti L, Mentuccia L, Vaccaro A, et al.
Breast Cancer Res Treat
. 2014 Sep;
147(3):599-607.
PMID: 25234842
Addition of trastuzumab to adjuvant chemotherapy has dramatically reduced the risk of recurrence and has become the standard of care for human epidermal growth factor receptor 2 (HER2)-positive early breast...
10.
Iacovelli R, Alesini D, Palazzo A, Trenta P, Santoni M, De Marchis L, et al.
Cancer Treat Rev
. 2013 Sep;
40(2):271-5.
PMID: 24070900
Antiangiogenic agents (AAs) have reported grater efficacy compared to interferon. Despite these advances, radiological complete response to therapy is rare. We meta-analyzed the incidence of complete response in patients treated...